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Arachidonic Acid, but Not Omega-3 Index, Relates to the Prevalence
and Progression of Abdominal Aortic Aneurysm in a Population-Based
Study of Danish Men
Jes S. Lindholt, MD, PhD; Katrine L. Kristensen, MD; Elena Burillo, PhD; Diego Martinez-Lopez, MSc; Carlos Calvo, BSc; Emilio Ros, MD,
PhD; Jose L. Martın-Ventura, PhD;* Aleix Sala-Vila, PhD*
Background-—Animal models support dietary omega-3 fatty acids protection against abdominal aortic aneurysm (AAA), but clinical
data are scarce. The sum of red blood cell proportions of the omega-3 eicosapentaenoic and docosahexaenoic acids, known as
omega-3 index, is a valid surrogate for long-term omega-3 intake. We investigated the association between the omega-3 index and
the prevalence and progression of AAA. We also investigated associations between AAA and arachidonic acid, an omega-6 fatty
acid that is a substrate for proinﬂammatory lipid mediators.
Methods and Results-—We obtained blood samples from 498 AAA patients (maximal aortic diameter ≥30 mm) within a
population-based ultrasound-screening trial in men and from 199 age-matched controls who screened negative. We determined
the fatty acids of red blood cells by gas chromatography. During a median follow-up of 4.85 years, 141 AAA patients reached
criteria for vascular surgical repair. Participants were high consumers of omega-3 (average omega-3 index: 7.6%). No signiﬁcant
associations were found for omega-3 index. In contrast, arachidonic acid in AAA patients was higher than in controls (P<0.001),
and individuals in the upper tertile of arachidonic acid at baseline had higher probability of having AAA (odds ratio: 1.309; 95%
conﬁdence interval, 1.021–1.678; P=0.033). AAA patients at the upper tertile of arachidonic acid at baseline had a 54% higher risk
of needing surgical repair during follow-up (hazard ratio: 1.544; 95% conﬁdence interval, 1.127–2.114; P=0.007).
Conclusions-—Omega-3 index is unrelated to men with AAA from a country in which ﬁsh consumption is customarily high.
Arachidonic acid is associated with AAA presence and progression.
Clinical Trial Registration-—URL: https://www.clinicaltrials.gov. Unique identiﬁer: NCT00662480. ( J Am Heart Assoc. 2018;7:
e007790. DOI: 10.1161/JAHA.117.007790.)
Key Words: abdominal aortic aneurysm • diet • inﬂammation
A bdominal aortic aneurysm (AAA) is characterized by afocal dilation of the aortic diameter ≥30 mm. AAA is
asymptomatic until aortic rupture, which is fatal in 90% of
cases. Main mechanisms of AAA are proteolysis and
oxidative stress, which triggers the inﬂammatory response
of the aortic wall, contributing to the AAA continuum.
Oxidative stress and particularly inﬂammation are inhibited
by the ﬁsh-derived omega-3 fatty acids eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA). This prompted
the notion that dietary omega-3 might protect against AAA.1
Such a hypothesis was conﬁrmed in experimental models
(angiotensin II–infused apolipoprotein E–knockout mice2–4).
To date, however, clinical data are limited to a recent study
conducted in a small Japanese population that reported a
low proportion of EPA in serum related to AAA growth and
size.5
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In the frame of a population-based ultrasound-screening
trial for AAA in Danish men aged 65 to 74 years (VIVA [Viborg
Vascular] trial6), we conducted an observational study that
aimed to test whether long-term intake of omega-3 related to
decreased prevalence and progression of AAA. In observa-
tional studies, the optimal approach to address this issue is by
using the fatty acid composition of body tissues, given the
difﬁculties of accurately measuring fat intake from the diet
records.7 Although the fatty acid proﬁle of adipose tissue is
the best surrogate of long-term fat intake, circulating fatty
acids are a convenient and accepted alternative.7 The
turnover of red blood cells (RBCs; 120-day life span) makes
RBCs more suitable for objective assessment of omega-3 fatty
acid status than serum or plasma.8 We focused on the sum of
proportions of EPA and DHA in RBCs, known as the omega-3
index, because it is a valid surrogate for long-term omega-3
intake9 and has been proposed as a risk factor for cardio-
vascular diseases, particularly sudden cardiac death.10 We
also determined the RBC proportion of arachidonic acid, an
omega-6 fatty acid that is a substrate for the synthesis of
proinﬂammatory lipid mediators once released from cell
membranes.
Materials and Methods
Data Availability
The authors conﬁrm that, for approved reasons, some
access restrictions apply to the data underlying the ﬁndings.
Access to the data can be requested by applying for
permission from the Danish Data Protection Agency and
Statistics Denmark.
Setting
This observational study was conducted in the frame of a
population-based image-screening trial for AAA in Danish men
aged 65 to 74 years (VIVA, ClinicalTrials.gov identiﬁer
NCT00662480). The protocol design has been reported in
detail elsewhere.6 In brief, between October 2008 and October
2010, 50 000 individuals were randomized to receive an
invitation for vascular screening or to be a control. In total,
18 750 of the 25 000 individuals offered vascular screening
agreed to participate. All participants gave informed consent,
and the local ethics committee of Viborg Hospital approved the
study, which was performed in accordance with the Helsinki
Declaration. Trained project nurses performed ultrasound
scans of the aorta; measured the ankle–brachial index; and
collected anthropometric, clinical, and lifestyle data in 3 mobile
units at local hospitals in the region of Jutland, Denmark.
To visualize the aorta, the ultrasound 4-MHz transducer
was placed longitudinally just above and a little to the left of
the navel. In cases of dilation, the maximal perpendicular
anteroposterior diameter was measured. If no dilation was
found, the anteroposterior diameter was measured 2 cm
above the bifurcation. In the case of infrarenal aortic
dilatation, such ﬁndings were pre-AAA (25–30 mm) or AAA
(≥30 mm). The interobserver variation of aortic diameter
measurements was 1.52 mm.11 Patients with AAA <50 mm
diameter were offered annual control scans by the screening
team, whereas patients with AAA ≥50 mm were referred for a
computed tomography scan and vascular surgical evaluation.
Elective surgery was conducted in patients with AAA
≥55 mm. If no repair was indicated, the vascular surgical
department took over management because of a need for
closer surveillance.
Ankle systolic blood pressure was also measured, and
maximal anterior–posterior diameter of the infrarenal aorta
was measured at the peak of systole from the inner edge to
the outer edge of the aorta. The ankle–brachial index was
calculated as the mean of the 2 recorded ankle arterial blood
pressures divided by the brachial systolic blood pressure.
Peripheral arterial disease was deﬁned as an ankle–brachial
index <0.90 or >1.4.
We obtained fasting blood samples at diagnosis from 498
AAA patients and 199 age-matched controls free of AAA and
peripheral arterial disease who were recruited from the
original cohort at baseline after the screening tests. Growth
rate was calculated based on the ultrasound scans from the
baseline and annual follow-up visits using individual linear
regression between sizes and time. During a median follow-up
of 4.85 years, 141 AAA patients reached size criteria for
recommending vascular repair. One participant in this cohort
had emergency surgery and was excluded from further
analyses.
Clinical Perspective
What Is New?
• Omega-3 index is not associated with abdominal aortic
aneurysm (AAA) presence and progression in Denmark, a
country with a high omega-3 index.
• Red blood cell arachidonic acid is related to increased
prevalence and progression of AAA.
What Are the Clinical Implications?
• Omega-3 index is not valuable as a biomarker of AAA, at
least in this cohort of patients with high fatty ﬁsh
consumption.
• Arachidonic acid is associated with AAA progression
independent of aortic size, suggesting its potential role as
a prognostic biomarker.
• Modulation of the arachidonic acid pathway could be a
therapeutic strategy to prevent AAA growth.
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RBC Membrane Fatty Acid Analysis
Overnight fasting-period (>10 hours) blood samples were
obtained by venipuncture and stored at 80°C until fatty acid
analysis. The RBC fatty acid proﬁle was determined, as
described.9 In brief, cells contained in a 100-lL aliquot of
EDTA-collected blood were hemolyzed and spun. The pellet
(>99% RBC membranes) was dissolved in 1 mL BF3 methanol
solution and heated to hydrolyze and methylate glycerophos-
pholipid fatty acids. The fatty acid methyl esters were isolated
by adding n-hexane and were separated by gas chromatog-
raphy using an Agilent HP 7890 gas chromatograph equipped
with a 30 m90.25 lm90.25 mm SupraWAX-280 capillary
column (Teknokroma), an autosampler, and a ﬂame ionization
detector. The amount of each fatty acid was expressed as a
percentage of the total identiﬁed fatty acids in the sample.
The omega-3 index was calculated as the sum of the
percentages of EPA and DHA. As reported,9 the fatty analysis
method has been cross-validated against the method used in
the original deﬁnition of the omega-3 index, with a coefﬁcient
of variance of 3% for EPA and DHA.12
Statistical Analyses
When the sampling occurred, the hypothesis about an
association between AAA and fatty acids had not yet been
formulated. To our knowledge, there is a single report of
data on RBC fatty acids in Denmark.13 Given that no data
on the omega-3 index are available, sample size was
calculated according to arachidonic acid. We assumed that
if the mean of arachidonic acid is 15.6 and standard
deviation is 1.51, the smallest detectable difference
between AAA and controls is 0.65, corresponding to
<5% of the mean at a 1% signiﬁcance level and 99% power,
suggesting a very robust study concerning the comparison
between controls and AAA patients. We could not ﬁnd any
reasonable assumptions to perform a power calculation
concerning need for later repair.
Normal distribution of data was assessed using graphical
methods and the Shapiro–Wilk test. Residuals were assessed
in histograms and p-p plots. Differences between AAA
patients and controls regarding exposures of interest
(omega-3 index and arachidonic acid) and main clinical
characteristics were assessed by Student t test. Independent
associations between AAA prevalence and both exposures
(arachidonic acid and omega-3 index) of interest (divided into
tertiles) were assessed by logistic regression analyses with
adjustments for active smoking, hypertension, use of statins,
use of low-dose aspirin, body mass index, diastolic blood
pressure, and peripheral arterial disease at screening. In
addition, in the subset of AAA patients, we used the Pearson
correlation coefﬁcient to study the association between
exposures of interest and maximal aortic diameter and
growth rate. Because of a nontransformable nonnormal
distribution of C-reactive protein, Spearman correlation tests
were used when exploring correlations with C-reactive
protein. We also explored whether patients at the upper
tertile of each exposure at baseline had an increased risk of
needing surgical repair. To address this issue, we obtained a
Kaplan–Meier curve for cumulative freedom by constructing a
multivariate Cox proportional hazards model, adjusted for
active smoking, hypertension, use of low-dose aspirin, use of
statins, peripheral arterial disease at screening, body mass
index, diabetes mellitus, use of beta blockers, C-reactive
protein, and baseline maximal aortic diameter.
Results
The Student t test revealed expected differences in clinical
characteristics between AAA patients and controls (Table 1).
No signiﬁcant differences were found between AAA patients
and controls for omega-3 index. The average omega-3 index
was 7.6% and was <4% (the proposed cutoff for high
cardiovascular risk10) in only 4.9% of the study population
(Figure 1A). Arachidonic acid proportion in AAA patients was
higher than in controls (meanSD: 15.90%2.58 versus
15.06%2.33, respectively; P<0.001; Figure 1B). Partici-
pants in the upper tertile of arachidonic acid at baseline
consistently had signiﬁcantly higher prevalence of AAA,
independent of potential confounding factors (adjusted odds
ratio: 1.309; 95% conﬁdence interval [CI], 1.021–1.678;
P=0.033; Table 2). In AAA patients, the proportion of
arachidonic acid in RBCs directly correlated with maximal
aortic diameter (R=0.091, P=0.042; Figure 2A) but not with
aneurysmal growth rate (R=0.020, P=0.702). No correla-
tion was noted concerning maximal aortic diameter and
aneurysmal growth rate for omega-3 index (R=0.037,
P=0.476, and R=0.001, P=0.979, respectively), EPA
(R=0.06, P=0.117, and R=0.02, P=0.967, respectively),
or DHA (R=0.08, P=0.872, and R=0.01, P=0.816, respec-
tively). Finally, after a median follow-up of 4.85 years, AAA
patients in the upper tertile of arachidonic acid at baseline
showed a 54% higher risk of needing surgical repair
(adjusted hazard ratio: 1.544; 95% CI, 1.127–2.114;
P=0.007; Figure 2B), independent of potential confounding
factors, including aortic diameter (Table 3). No signiﬁcant
associations were found in AAA patients in the upper tertile
of EPA (hazard ratio: 0.957; 95% CI, 0.709–1.292; P=0.773),
DHA (hazard ratio: 0.832; 95% CI, 0.613–1.130; P=0.239),
or omega-3 index (hazard ratio: 0.906; 95% CI, 0.669–1.227;
P=0.520). Finally, C-reactive protein levels inversely corre-
lated with EPA (R=0.112, P=0.015), DHA (R=0.148,
P=0.001), and the omega-3 index (R=0.147, P=0.001), but
no signiﬁcant correlation was found for arachidonic acid
levels (R=0.052, P=0.261).
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Discussion
The main conclusion of our study is that in a population with a
high intake of omega-3, the omega-3 index was unrelated to
AAA. In contrast, the RBC proportion of arachidonic acid, a
substrate for generation of lipid mediators with proinﬂamma-
tory properties, related to an increased prevalence of AAA
and, in those diagnosed with AAA, an increased risk of
needing surgical repair.
Although the role of EPA and DHA in primary prevention of
coronary heart disease has long been explored, clinical
research on omega-3 and AAA is limited to a recent study
conducted in 67 Japanese participants with AAA. Aikawa et al
reported that the proportion of EPA in serum, a surrogate
marker for EPA intake,7 inversely related to AAA size and
growth after a mean follow-up of 30.6 months.5 In conﬂict
with this ﬁnding, we found that in our population, omega-3 in
RBC membranes was unrelated to both AAA prevalence and
progression. This discrepancy could underlie several issues.
First, the use of fatty acid composition of total serum, which
does not reﬂect long-term intake as accurately as adipose
tissue or RBC do,7 precludes the adscription of observed
Table 1. Clinical Baseline Characteristics of the Study Population
AAA (n=498)
Age-Matched
Controls (n=199) P Value*
AAA, Vascular
Repair (n=141)
AAA, No Repair
(n=357) P Value†
Baseline aortic size, mm 40.8 (11.8) 18.3 (3.0) <0.001 47.7 (13.7) 35.6 (6.4) <0.001
PAD, n (%) 130 (26.1) 0‡ <0.001 27 (19.1) 103 (28.9) 0.013
BMI, kg/m2 27.4 (3.6) 26.2 (3.3) <0.001 27.4 (3.5) 27.3 (3.7) 0.640
Current smoking, n (%) 203 (40.8) 39 (19.6) <0.001 57 (40.4) 146 (40.9) 0.878
Diabetes mellitus, n (%) 54 (10.8) 29 (14.6) 0.181 15 (10.6) 39 (10.9) 0.608
Hypertension, n (%) 266 (53.3) 91 (45.7) 0.030 80 (56.7) 186 (52.1) 0.305
Diastolic blood pressure, mm Hg 87.9 (12.1) 81.1 (10.2) <0.001 89.1 (12.5) 87.0 (11.8) 0.064
Use of statins, n (%) 260 (52.1) 73 (36.7) <0.001 74 (52.5) 186 (52.1) 0.972
Use of low-dose aspirin, n (%) 247 (49.5) 54 (27.1) <0.001 64 (45.4) 183 (51.3) 0.199
Use of bronchodilators, n (%) 39 (7.8) 11 (5.5) 0.260 8 (5.7) 31 (8.7) 0.289
Use of beta blockers, n (%) 150 (30.1) 46 (23.1) 0.053 35 (24.8) 115 (32.2) 0.079
Data are expressed as mean (SD), except for quantitative variables, expressed as %. AAA indicates abdominal aortic aneurysm; BMI, body mass index; PAD, peripheral artery disease.
*Comparison between AAA and controls. P obtained by Student t test.
†Comparison between AAA needing vascular repair vs not. P obtained by Student t test.
‡Controls were free of PAD by deﬁnition.
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Figure 1. Red blood cell proportions (percentage of total fatty acids) of (A) eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA)(EPA+DHA=omega-3 index) and (B) arachidonic acid in 498 patients with
abdominal aortic aneurysm (AAA) and 199 age-matched controls who screened negative. Dots are individual
participant data, and bars represent meanSD. P obtained by Student t test. In panel (A), discontinuous lines
at 8% and 4% indicate proposed low- and high-risk cutoffs for cardiovascular risk, respectively.10
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effects to membrane changes with long-term omega-3 intake.
In contrast, the omega-3 fatty acid status in RBCs has stability
documented over a 6-week period8; the use of RBCs also
allowed us to examine the omega-3 index, deﬁned as the sum
of the percentages of EPA and DHA in RBC membranes, and
its role as a risk marker for cardiovascular disease is
emerging. Second, the number of AAA patients in our study
was noticeably larger and had longer follow-up. Third, white
race is a well-deﬁned risk factor associated with the
development of AAA, thus hampering direct comparisons
regarding the inﬂuence of environmental risk factors for AAA
between Asian and Western populations.
A plausible explanation for our neutral ﬁndings on omega-3
and AAA could be the existence of a threshold of protection of
EPA and DHA against AAA in non-Asian individuals, largely
exceeded by both controls and AAA patients in our study
(given the average omega-3 index of 7.6% in our population).
This value resembles those described in other Scandinavian
populations,14 resulting from the customarily high consump-
tion of fatty ﬁsh in this area.15,16 Future research should
conﬁrm or dispel whether the beneﬁts of increasing dietary
EPA and DHA on AAA would be observed only with a low
background intake of omega-3. This would be similar to
prevention of coronary heart disease, for which few beneﬁts
Table 2. Independent Determinants of AAA by Multivariate Logistic Regression
Variable B SE OR (95% CI) P Value
Being at the upper tertile of
arachidonic acid at baseline, yes
0.269 0.127 1.309 (1.021–1.678) 0.033
Current smoking, yes 1.413 0.248 4.110 (2.528–6.682) <0.001
Hypertension, yes 0.062 0.211 1.064 (0.703–1.610) 0.768
Use of low-dose aspirin, yes 1.082 0.249 2.951 (1.809–4.812) <0.001
Use of statin, yes 0.178 0.238 1.194 (0.750–1.903) 0.454
PAD, yes 2.233 0.486 9.331 (3.598–24.197) <0.001
BMI, increase by 1 kg/m2 0.088 0.032 1.092 (1.026–1.162) 0.005
DBP, increase by 1 mm Hg 0.074 0.010 1.077 (1.056–1.099) <0.001
Constant 9.144 1.184 0.0002 <0.001
AAA indicates abdominal aortic aneurysm; BMI, body mass index; CI, conﬁdence interval; DBP, diastolic blood pressure; OR. odds ratio; PAD, peripheral artery disease.
Number at risk 
upper tertile 166 137 123 106 89 60 16
medium + lower tertile 332 281 255 220 195 117 42
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Figure 2. In 498 patients with abdominal aortic aneurysm (AAA), (A) a scatter plot shows the red blood
cell proportion of arachidonic acid and the maximal aneurysm diameter, and (B) the Kaplan–Meier curve
shows cumulative freedom from needing vascular repair, stratiﬁed by being in the upper tertile of red blood
cell proportion of arachidonic acid at baseline vs not. Data were obtained using a multivariate Cox
proportional hazards model adjusted for active smoking, hypertension, use of low-dose aspirin, use of
statins, peripheral arterial disease at screening, body mass index, diabetes mellitus, use of beta blockers,
C-reactive protein, and baseline maximal aortic diameter.
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are observed beyond intakes of 500 mg/d,17 an amount
easily achievable through 2 weekly servings of fatty ﬁsh. Of
particular interest are cohorts in the United States, a country
with low omega-3 index14 and high AAA prevalence.18
We observed increased levels of arachidonic acid in AAA
patients. Although EPA and DHA act by generating anti-
inﬂammatory and vasoprotective compounds (eg, lipoxins,
protectins, maresins), arachidonic acid mostly generates
proinﬂammatory molecules on release of cell membranes.
Arachidonic acid levels at baseline were associated with
increased need of surgical repair independent of C-reactive
protein. Interestingly, C-reactive protein showed no associa-
tion with arachidonic acid, whereas signiﬁcant inverse asso-
ciations were observed for omega-3 fatty acids. These
ﬁndings support the view that the association of arachidonic
acid with AAA presence and progression is not simply a
reﬂection of increased systemic inﬂammation. However, the
absence of correlation with C-reactive protein does not
preclude the potential contribution of arachidonic acid to
vascular (local) inﬂammatory response. In this regard,
increased levels of leukotriene B4 (an arachidonic acid-
derived compound) have been observed in tissues of AAA
patients.19 Moreover, protection against experimental AAA
was afforded by blockade of enzymes involved in arachidonic
acid metabolism, such as lipooxygenase.20 Further research is
needed to identify determinants of arachidonic acid in cell
membranes and to elucidate the role of this fatty acid,
particularly regarding its lipid-derived mediators, on AAA
progression.
The main limitation of our study is its observational
design. A cause–effect relationship would be established only
by a randomized controlled trial involving a nutritional
intervention in a large population, ideally, with low
background omega-3 intake and high risk of AAA, followed
for several years. In addition, cumulative average estimates of
arachidonic acid would provide a more robust association
with AAA progression than a single baseline measurement.
The study also has strengths. Selection bias seems unlikely
because the study group members were participants in a
population-based screening trial with an attendance rate of
74%.21 Information bias also seems unlikely because ultra-
sound-based measurement of the aorta was performed by a
validated method showing high position, and information on
the need for later AAA repair was based on nationwide
registry data in which all AAA repair procedures are recorded
by law and for reimbursement.22 Consequently, all partici-
pants had follow-up without missing data. Finally, the
analyses were adjusted for known potential risk factors for
AAA.
In conclusion, we found that omega-3 index, an objective
marker of omega-3 intake, was unrelated to AAA in men from
a country in which ﬁsh consumption is customarily high. In
contrast, the content of arachidonic acid was related to
prevalence and progression of AAA.
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Diabetes mellitus, yes 0.042 0.280 0.959 (0.554–1.658) 0.880
Use of beta blockers, yes 0.314 0.199 0.730 (0.494–1.079) 0.730
C-reactive protein, increase by 1 mg/L <0.001 0.007 1.000 (0.985–1.014) 0.953
Baseline aortic size, increase by 1 mm 0.083 0.005 1.087 (1.076–1.097) <0.001
AAA indicates abdominal aortic aneurysm; BMI, body mass index; CI, conﬁdence interval; HR. hazard ratio; PAD, peripheral artery disease.
DOI: 10.1161/JAHA.117.007790 Journal of the American Heart Association 6
Omega-3 and Abdominal Aortic Aneurysm Lindholt et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on January 29, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
of Economy and Competitiveness through the Instituto de
Salud Carlos III (Spain).
Disclosures
None.
References
1. Meital LT, Sandow SL, Calder PC, Russell FD. Abdominal aortic anurysm and
omega-3 polyunsaturated fatty acids: mechanisms, animal models, and
potential treatment. Prostaglandins Leukot Essent Fatty Acids. 2017;118:1–9.
2. Wang JH, Eguchi K, Matsumoto S, Fujiu K, Komuro I, Nagai R, Manabe I. The
x-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal
aortic aneurysm development via suppression of tissue remodeling. PLoS One.
2014;9:e96286.
3. Yoshihara T, Shimada K, Fukao K, Sai E, Sato-Okabayashi Y, Matsumori R,
Shiozawa T, Alshahi H, Miyazaki T, Tada N, Daida H. Omega 3 polyunsaturated
fatty acids suppress the development of aortic aneurysms through the
inhibition of macrophage-mediated inﬂammation. Circ J. 2015;79:1470–1478.
4. Kavazos K, Nataatmadja M, Wales KM, Hartland E, Williams C, Russell FD.
Dietary supplementation with omega-3 polyunsaturated fatty acids modulate
matrix metalloproteinase immunoreactivity in a mouse model of pre-abdominal
aortic aneurysm. Heart Lung Circ. 2015;24:377–385.
5. Aikawa T, Miyazaki T, Shimada K, Sugita Y, Shimizu M, Ouchi S, Kadoguchi T,
Yokoyama Y, Shiozawa T, Hiki M, Takahashi S, Al Shahi H, Dohi S, Amano A,
Daida H. Low serum levels of EPA are associated with the size and growth rate
of abdominal aortic aneurysm. J Atheroscler Thromb. 2017;24:912–920.
6. Grøndal N, Søgaard R, Henneberg EW, Lindholt JS. The Viborg Vascular (VIVA)
screening trial of 65-74 year old men in the central region of Denmark: study
protocol. Trials. 2010;11:67.
7. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue
and blood in humans and its use as a biomarker of dietary intake. Prog Lipid
Res. 2008;47:348–380.
8. Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers.
Clin Biochem. 2010;43:338–340.
9. Sala-Vila A, Harris WS, Cofan M, Perez-Heras AM, Pinto X, Lamuela-Raventos
RM, Covas MI, Estruch R, Ros E. Determinants of the omega-3 index in a
Mediterranean population at increased risk for CHD. Br J Nutr. 2011;106:425–
431.
10. Harris WS. The omega-3 index: from biomarker to risk marker to risk factor.
Curr Atheroscler Rep. 2009;11:411–417.
11. Grøndal N, Bramsen MB, Thomsen MD, Rasmussen CB, Lindholt JS. The
cardiac cycle is a major contributor to variability in size measurements of
abdominal aortic aneurysms by ultrasound. Eur J Vasc Endovasc Surg.
2012;43:30–33.
12. Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ. Changes in erythrocyte
membrane trans and marine fatty acids between 1999 and 2006 in older
Americans. J Nutr. 2012;142:1297–1303.
13. Lauritzen L, Harsløf LB, Hellgren LI, Pedersen MH, Mølgaard C, Michaelsen KF.
Fish intake, erythrocyte n-3 fatty acid status and metabolic health in Danish
adolescent girls and boys. Br J Nutr. 2012;107:697–704.
14. Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N Jr. Global
survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapen-
taenoic acid in the blood stream of healthy adults. Prog Lipid Res.
2016;63:132–152.
15. Micha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG, Engell RE, Powles
J, Ezzati M, Mozaffarian D; Global Burden of Diseases Nutrition and Chronic
Diseases Expert Group NutriCoDE. Global, regional, and national consumption
levels of dietary fats and oils in 1990 and 2010: a systematic analysis
including 266 country-speciﬁc nutrition surveys. BMJ. 2014;348:g2272.
16. Welch AA, Lund E, Amiano P, Dorronsoro M, Brustad M, Kumle M, Rodriguez
M, Lasheras C, Janzon L, Jansson J, Luben R, Spencer EA, Overvad K,
Tjønneland A, Clavel-Chapelon F, Linseisen J, Klipstein-Grobusch K, Benetou V,
Zavitsanos X, Tumino R, Galasso R, Bueno-De-Mesquita HB, Ocke MC,
Charrondiere UR, Slimani N. Variability of ﬁsh consumption within the 10
European countries participating in the European Investigation into Cancer and
Nutrition (EPIC) study. Public Health Nutr. 2002;5:1273–1285.
17. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health:
evaluating the risks and the beneﬁts. JAMA. 2006;296:1885–1899.
18. Li X, Zhao G, Zhang J, Duan Z, Xin S. Prevalence and trends of the abdominal
aortic aneurysms epidemic in general population-a meta-analysis. PLoS One.
2013;8:e81260.
19. Houard X, Ollivier V, Louedec L, Michel JB, B€ack M. Differential inﬂammatory
activity across human abdominal aortic aneurysms reveals neutrophil-derived
leukotriene B4 as a major chemotactic factor released from the intraluminal
thrombus. FASEB J. 2009;23:1376–1383.
20. Bhamidipati CM, Whatling CA, Mehta GS, Meher AK, Hajzus VA, Su G, Salmon
M, Upchurch GR Jr, Owens GK, Ailawadi G. 5-Lipoxygenase pathway in
experimental abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol.
2014;34:2669–2678.
21. Grøndal N, Søgaard R, Lindholt JS. Baseline prevalence of abdominal aortic
aneurysm, peripheral arterial disease and hypertension in men aged
65-74 years from a population screening study (VIVA trial). Br J Surg.
2015;102:902–906.
22. Laustsen J, Jensen LP, Hansen AK; Danish National Vascular Registry.
Accuracy of clinical data in a population based vascular registry. Eur J Vasc
Endovasc Surg. 2004;27:216–219.
DOI: 10.1161/JAHA.117.007790 Journal of the American Heart Association 7
Omega-3 and Abdominal Aortic Aneurysm Lindholt et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on January 29, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Ros, Jose L. Martín-Ventura and Aleix Sala-Vila
Jes S. Lindholt, Katrine L. Kristensen, Elena Burillo, Diego Martinez-Lopez, Carlos Calvo, Emilio
Based Study of Danish Men−Abdominal Aortic Aneurysm in a Population
 3 Index, Relates to the Prevalence and Progression of−Arachidonic Acid, but Not Omega
Online ISSN: 2047-9980 
Dallas, TX 75231
 is published by the American Heart Association, 7272 Greenville Avenue,Journal of the American Heart AssociationThe 
doi: 10.1161/JAHA.117.007790
2018;7:e007790; originally published January 26, 2018;J Am Heart Assoc. 
 http://jaha.ahajournals.org/content/7/3/e007790
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
 
 for more information. http://jaha.ahajournals.orgAccess publication. Visit the Journal at 
 is an online only OpenJournal of the American Heart AssociationSubscriptions, Permissions, and Reprints: The 
 by guest on January 29, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
